Opportunistic Infections in Patients Receiving Daratumumab Regimens for Multiple Myeloma (MM)

被引：4
|
作者：
Burns, Ethan A. [1 ]
Ensor, Joe E. [2 ]
Anand, Kartik [3 ]
Gentille, Cesar [4 ]
Guerrero, Carlo [1 ]
Kieser, Ryan B. [1 ]
Umoru, Godsfavor [5 ]
Shah, Shilpan S. [1 ]
Petkova, Jenny H. [6 ]
Ganguly, Siddhartha [6 ,7 ]
Rice, Lawrence [8 ]
Pingali, Sai Ravi Kiran [1 ]
机构：
[1] Houston Methodist Canc Ctr, Houston, TX USA
[2] Houston Methodist Res Inst, Houston, TX USA
[3] Callahan Canc Ctr, Great Plains Hlth, North Platte, NE USA
[4] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA 94305 USA
[5] Houston Methodist Hosp, Dept Pharm, Houston, TX 77030 USA
[6] Houston Methodist Hosp, Houston, TX 77030 USA
[7] Ctr Canc, Houston, TX USA
[8] Houston Methodist Hosp, Dept Med, Weill Cornell Med Collage, Houston, TX 77030 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4740
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
    Al Saleh, Abdullah S.
    Sidiqi, M. Hasib
    Gertz, Morie A.
    Muchtar, Eli
    Lacy, Martha Q.
    Warsame, Rahma M.
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Hogan, William J.
    Hayman, Suzanne R.
    Kapoor, Prashant
    Buadi, Francis K.
    Dispenzieri, Angela
    Dingli, David
    Kumar, Shaji K.
    BLOOD, 2019, 134
  • [32] Daratumumab for multiple myeloma
    Croizier, Carolyne
    Bailly, Sebastien
    BULLETIN DU CANCER, 2018, 105 (11) : 985 - 991
  • [33] Transfusion management in multiple myeloma patients receiving daratumumab: Experience of a single tertiary care centre
    Solves, Pilar
    Tur, Susana
    Arnao, Mario
    Freiria, Carmen
    Dominguez, Lara
    Jesus Pons, M.
    Gomez, Ines
    Sanz, G. F.
    Carpio, N.
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (02)
  • [34] Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Myeloma Receiving Daratumumab and Pomalidomide
    Monge, Jorge
    Contreras, Jorge
    Elsoukkary, Sarah
    Guo, Jin
    Perry, Art
    Solomon, Robin S.
    Flicker, Kari
    Jayabalan, David S.
    Coleman, Morton
    Rossi, Adriana C.
    Harris, Rebecca
    Plate, Markus
    Stuebgen, Joerg-Patrick
    Niesvizky, Ruben
    BLOOD, 2019, 134
  • [35] Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma
    Wang, Jiasheng
    Arroyo-Suarez, Raul
    Tse, William
    BLOOD, 2021, 138 : 3806 - +
  • [36] Prevention of dental complications in patients with multiple myeloma (MM) receiving bisphosphonates treatment
    Puigmarti, C. L.
    Santos, N.
    Mostacedo, S.
    Gonzalez, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? - Literature review
    Ferreira, Luana Mota
    Cerezer, Jaderson Lima
    Gehrcke, Mailine
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (02) : 185 - 190
  • [38] Split dosing of daratumumab (D) in a phase 1b study of D plus carfilzomib (K)-based regimens in patients (pts) with multiple myeloma (MM)
    Usmani, S. Z.
    Jakubowiak, A.
    Chari, A.
    Lonial, S.
    Mateos, M-V.
    Benboubker, L.
    Wu, K.
    Khokhar, N. Z.
    Wang, J.
    Doshi, P.
    Moreau, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Successful Conversion and Implementation to Subcutaneous Daratumumab in Patients with Multiple Myeloma ( MM) and Light Chain (AL) Amyloidosis
    Hughes, David
    Henshaw, Lynnette
    Blevins, Frances
    Edwards, Camille V.
    Lerner, Adam
    Sloan, John Mark
    Sanchorawala, Vaishali
    BLOOD, 2021, 138 : 1975 - +
  • [40] Clinical Characteristics and Transfusion Management of Patients Diagnosed of Multiple Myeloma Receiving Daratumumab: Experience of a Single Centre
    Arnao, Mario
    Solves, Pilar
    Blanco, Albert
    Dominguez, Lara
    Gomez, Ines
    Andreu, Rafa
    Romero, Samuel
    Jarque, Isidro
    Carpio, Nelly
    Sanz, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E152 - E153
12345